Journal of Medicinal Chemistry · 2007 · 59 citations · 33 references
MedicineMedicinal ChemistryPharmacologyCancer PharmacologyDrug DesignDrug DiscoveryEnzyme InhibitionOncology PharmacologyTopoisomerase InhibitorsAmino Group ReplacementBiological Activity FeaturesCatalytic Topoisomerase InhibitionDna Topoisomerase I InhibitionPyridine ChemistrySubstituent Effects On Biological ActivityTopoisomerase ActivityTopoisomerase I Inhibitors
Indenoisoquinolines with lactam substituents such as ethylamino, propylamino, and butylamino have previously demonstrated potent biological activity, but an optimal length has never been established. In the present study, a series of simplified indenoisoquinoline analogues possessing a linker spacing of 0-12 carbon atoms between the lactam nitrogen and the terminal amino group have been prepared, determining that 2-4-atom lengths are optimal for topoisomerase I inhibition and cytotoxicity. Using these lengths, analogues were prepared with the amino group and portions of the linker replaced by a pyridine ring. A three-carbon spacer within the pyridine series still demonstrated potent topoisomerase I inhibition.
33
New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening
Philip Skehan, Ritsa Storeng, Dominic A. Scudiero et al. · JNCI Journal of the National Cancer Institute · 1990 · 9.8K citations
Medicine, Oncology, Pharmacology +10
Christine Jaxel, Kurt W. Kohn, Mansukh C. Wani et al. · PubMed · 1989 · 450 citations